IP Library Granted Patent US 10,926,054
Granted Patent B2
US 10,926,054 · App. 15/469,447 · Granted Feb 23, 2021

Systems and devices for generating nitric oxide

Inventors: David H. Fine (Cocoa Beach, FL); Bryan Johnson (Orlando, FL); Gregory Vasquez (Cocoa, FL)
Assignee: Vero Biotech LLC
A61M16/12A61M16/10A61M16/104A61M16/107A61M16/109A61M16/1075A61M16/16A62B7/08A62B21/00A61M2202/0275
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,926,054
App. No.
15/469,447
Granted
Feb 23, 2021
Kind
B2
Abstract

Various systems and devices for generating nitric oxide are disclosed herein. According to one embodiment, the device includes a body having an inlet, an outlet, and a porous solid matrix positioned with the body. The porous solid matrix is coated with an aqueous solution of an antioxidant, wherein the inlet is configured to receive a gas flow and fluidly communicate the gas flow to the outlet through the solid matrix to convert nitrogen dioxide in the gas flow into nitric oxide. The porous solid matrix allows the device to be used in any orientation. Additionally, the porous solid matrix provides a rigid structure suitable to withstand vibrations and abuse without compromising device functionality.

Claims (21)

1. A device for generating nitric oxide from nitrogen dioxide, comprising

a body including an inlet and outlet;

a sintered porous thermoplastic solid matrix within the body;

a silica gel embedded in pores of the sintered porous thermoplastic solid matrix; and

an aqueous solution of antioxidant wetting the sintered porous thermoplastic solid matrix and the silica gel,

the inlet configured to receive a gas flow and fluidly communicate the gas flow to the outlet through the sintered porous thermoplastic solid matrix to convert nitrogen dioxide in the gas flow into nitric oxide.

2. The device of claim 1 , further comprising a humidifier in communication with the inlet of the body.

3. The device of claim 1 , wherein the antioxidant is ascorbic acid, alpha tocopherol, or gamma tocopherol.

4. The device of claim 1 , wherein the sintered porous thermoplastic solid matrix comprises at least 20% silica gel.

5. The device of claim 1 , wherein the sintered porous thermoplastic solid matrix comprises 20% to 60% silica gel.

6. The device of claim 1 , wherein a density of the silica gel is the same as a density of a thermoplastic resin used to form the sintered porous thermoplastic solid matrix.

7. The device of claim 1 , wherein a density of the silica gel and a density of the sintered porous thermoplastic resin are configured such that a distribution of silica gel within the porous thermoplastic solid matrix is uniform.

8. A method, comprising:

mixing a thermoplastic resin and silica gel to form a powder mixture;

sintering the powder mixture to form a solid matrix having silica gel embedded in pores of the solid matrix; and

wetting the solid matrix with an aqueous solution of antioxidant.

9. The method of claim 8 , further comprising:

flowing nitrogen dioxide-containing gas over the solid matrix after wetting the solid matrix with the aqueous solution of antioxidant to form nitric oxide.

10. The method of claim 8 , further comprising:

flowing nitrogen dioxide-containing gas over the solid matrix after wetting the solid matrix with the aqueous solution of antioxidant to form nitric oxide; and

administering the nitric oxide to a patient.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Mar 18, 2026
From: HORIZON TECHNOLOGY FINANCE CORPORATION
To: VERO BIOTECH INC.
Reel/Frame 075308/0198 →
SECURITY INTEREST Recorded Mar 16, 2026
From: VERO BIOTECH INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS COLLATERAL AGENT
Reel/Frame 075117/0935 →
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 3, 2024
From: RUNWAY GROWTH FINANCE CORP (F/K/A RUNWAY GROWTH CREDIT FUND INC.)
To: VERO BIOTECH INC. (F/K/A VERO BIOTECH LLC)
Reel/Frame 066186/0611 →
SECURITY INTEREST Recorded Jan 3, 2024
From: VERO BIOTECH INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 066187/0865 →
CHANGE OF NAME Recorded Feb 14, 2022
From: VERO BIOTECH LLC
To: VERO BIOTECH INC.
Reel/Frame 059085/0418 →
SECURITY INTEREST Recorded Dec 29, 2020
From: VERO BIOTECH LLC
To: RUNWAY GROWTH CREDIT FUND INC.
Reel/Frame 054866/0589 →
CHANGE OF NAME Recorded Aug 7, 2018
From: GENO LLC
To: VERO BIOTECH LLC
Reel/Frame 048173/0247 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2017
From: FINE, DAVID H.; JOHNSON, BRYAN; VASQUEZ, GREGORY
To: GENO LLC
Reel/Frame 043073/0358 →
Cited By (1)
US 12,661,477